Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insights into idarubicin antimicrobial activity against methicillin-resistant Staphylococcus aureus
Pengfei She, Shijia Li, Linying Zhou, et al.
Virulence (2020) Vol. 11, Iss. 1, pp. 636-651
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Evaluation of potential anti-RNA-dependent RNA polymerase (RdRP) drugs against the newly emerged model of COVID-19 RdRP using computational methods
Alireza Poustforoosh, Hassan Hashemipour, Burak Tüzün, et al.
Biophysical Chemistry (2021) Vol. 272, pp. 106564-106564
Open Access | Times Cited: 66
Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline
Yuhang Wang, Junfeng Su, Ziyan Zhou, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 17
Antimicrobial, Antibiofilm, and Anti-persister Activities of Penfluridol Against Staphylococcus aureus
Yaqian Liu, Pengfei She, Lanlan Xu, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 36
Upcycling the anthracyclines: New mechanisms of action, toxicology, and pharmacology
Claudine E. Bayles, Danielle E. Hale, Ali Konieczny, et al.
Toxicology and Applied Pharmacology (2022) Vol. 459, pp. 116362-116362
Open Access | Times Cited: 21
Repurposing cinacalcet suppresses multidrug-resistant Staphylococcus aureus by disruption of cell membrane and inhibits biofilm by targeting IcaR
Zuye Fang, Zi-Yuan Zhang, Yun-Dan Zheng, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 4, pp. 903-917
Closed Access | Times Cited: 4
Diclofenac Sodium Restores the Sensitivity of Colistin-Resistant Gram-Negative Bacteria to Colistin
Qingxia Fu, Sichen Liu, Panjie Hu, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 8, pp. 2860-2869
Closed Access | Times Cited: 3
Repurposing Antispasmodic Agent Otilonium Bromide for Treatment of Staphylococcus aureus Infections
Linying Zhou, Pengfei She, Fang Tan, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 25
Flufenamic Acid, a Promising Agent for the Sensitization of Colistin-Resistant Gram-Negative Bacteria to Colistin
Yi Zhang, Yijia Han, Lingbo Wang, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 8
In vitro screening of compounds from the Food and Drug Administration-approved library identifies anti-Babesia gibsoni activity of idarubicin hydrochloride and vorinostat
Hang Li, Eloiza May Galon, Shengwei Ji, et al.
Parasitology International (2023) Vol. 96, pp. 102774-102774
Open Access | Times Cited: 8
Discovery of Salifungin as a Repurposed Antibiotic against Methicillin-Resistant Staphylococcus aureus with Limited Resistance Development
Chenchen Wang, Yueyue Ji, Xingyu Huo, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 5, pp. 1576-1589
Closed Access | Times Cited: 2
Insights into small-molecule compound CY-158-11 antibacterial activity against Staphylococcus aureus
Shen Li, Junhong Shi, Weihua Han, et al.
mSphere (2024)
Open Access | Times Cited: 2
Bactericidal and anti-quorum sensing activity of repurposing drug visomitin against staphylococcus aureus
Ruolan Wu, Yuan Wu, Pingyun Wu, et al.
Virulence (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Overcoming antibiotic resistance: the potential and pitfalls of drug repurposing
Mohammad Abavisani, Alireza Khoshrou, S. Eshaghian, et al.
Journal of drug targeting (2024), pp. 1-27
Closed Access | Times Cited: 2
Insights into the antimicrobial effects of ceritinib against Staphylococcus aureus in vitro and in vivo by cell membrane disruption
Shasha Liu, Pengfei She, Zehao Li, et al.
AMB Express (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Eugenol works synergistically with colistin against colistin-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae isolates by enhancing membrane permeability
Jingchun Kong, Yue Wang, Zhuocheng Yao, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 6
Combined With Mefloquine, Resurrect Colistin Active in Colistin-Resistant Pseudomonas aeruginosa in vitro and in vivo
Xiaodong Zhang, Yining Zhao, Luozhu Feng, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 14
Anti-hepatitis C virus drug simeprevir: a promising antimicrobial agent against MRSA
Yimin Li, Pengfei She, Lanlan Xu, et al.
Applied Microbiology and Biotechnology (2022) Vol. 106, Iss. 7, pp. 2689-2702
Closed Access | Times Cited: 9
Repurposing of the antimalarial agent tafenoquine to combat MRSA
Pengfei She, Yifan Yang, Linhui Li, et al.
mSystems (2023) Vol. 8, Iss. 6
Open Access | Times Cited: 5
Pixantrone Sensitizes Gram-Negative Pathogens to Rifampin
Pengfei She, Zehao Li, Yimin Li, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 8
Insights into the antimicrobial effects of tafenoquine against Enterococcus and its biofilms
Yuan Wu, Huilong Li, Pingyun Wu, et al.
Journal of Applied Microbiology (2024) Vol. 135, Iss. 1
Closed Access | Times Cited: 1
Drug repurposing: insights into the antimicrobial effects of AKBA against MRSA
Yingjia Li, Hongbing Ma
AMB Express (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Repurposing Candesartan Cilexetil as Antibacterial Agent for MRSA Infection
Lanlan Xu, Pengfei She, Lihua Chen, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 9
Repurposing CD5789 as an Antimicrobial Agent Against MRSA and Its High Resistant Phonotypes
Zhengli Hou, Biming Zhang, Zuoxun Xiao, et al.
Current Microbiology (2023) Vol. 80, Iss. 7
Closed Access | Times Cited: 3
Triple combination of SPR741, clarithromycin, and erythromycin againstAcinetobacter baumanniiand its tolerant phenotype
Zehao Li, Pengfei She, Yaqian Liu, et al.
Journal of Applied Microbiology (2022) Vol. 134, Iss. 1
Open Access | Times Cited: 5
Inhibitory effects of simeprevir on
Yingjia Li, Chaoni Cai, Zixin Liu, et al.
PubMed (2023) Vol. 48, Iss. 6, pp. 868-876
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top